Get the Stockscreener App
80.04
5.57%
4.22
Dexcom Inc stock is traded at $80.04, with a volume of 10.40M.
It is up +5.57% in the last 24 hours and up +6.38% over the past month.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$75.82
Open:
$75.47
24h Volume:
10.40M
Relative Volume:
2.56
Market Cap:
$31.26B
Revenue:
$3.95B
Net Income/Loss:
$680.80M
P/E Ratio:
87.96
EPS:
0.91
Net Cash Flow:
$535.00M
1W Performance:
+3.69%
1M Performance:
+6.38%
6M Performance:
-31.04%
1Y Performance:
-31.38%
1-Day Range:
$75.47
$81.51
1-Week Range:
$74.50
$81.51
52-Week Range:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
80.04 | 31.26B | 3.95B | 680.80M | 535.00M | 1.67 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
DexCom (NASDAQ:DXCM) Trading 7.3% HigherStill a Buy? - MarketBeat
Orion Portfolio Solutions LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Ōura closes $200M series D, Dexcom invests $75M - BioWorld Online
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada - MSN
Oura boosts valuation to $5.2B in latest funding round (NASDAQ:DXCM) - Seeking Alpha
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement - Business Wire
UPC latest: CoA decision has retroactive effect | Dexcom defeat | 2025 predictions - Managing Intellectual Property
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024DXCM - The Eastern Progress Online
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Dexcom implements GenAI into glucose biosensor devices - Yahoo Finance
Dexcom adds generative AI to over-the-counter CGMs - MedTech Dive
Insiders At DexCom Sold US$18m In Stock, Alluding To Potential Weakness - Simply Wall St
AI-Driven Glucose Biosensing: Dexcom’s (DXCM) Path To A Comeback - Yahoo Finance
Dexcom director Bridgette Heller sells shares for $76,870 By Investing.com - Investing.com Australia
Dexcom's COO Jacob Leach sells $57,191 in stock By Investing.com - Investing.com South Africa
Dexcom director Bridgette Heller sells shares for $76,870 - Investing.com India
Dexcom's COO Jacob Leach sells $57,191 in stock - Investing.com
Dexcom launches generative AI platform for glucose biosensing - Mass Device
Dexcom Rolls Out GenAI Platform for Stelo CGM - MPO-mag
Dexcom Launches First-Ever GenAI Platform for Glucose Monitoring, Partners with Google Cloud - StockTitan
Dexcom G7 CGM System Now Covered by Alberta Government for Type 1 & 2 Diabetes Patients - StockTitan
Is Dexcom, Inc. (DXCM) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Dexcom shares up as Diabetes Association updates guidelines - MSN
Lord Abbett & CO. LLC Sells 23,004,568 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
MML Investors Services LLC Reduces Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - MSN
DexCom, Inc. (NASDAQ:DXCM) Short Interest Update - MarketBeat
DexCom's SWOT analysis: cgm maker faces challenges amid stock volatility - Investing.com
Tidal Investments LLC Raises Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
World Investment Advisors LLC Purchases Shares of 35,066 DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Virtu Financial LLC Buys New Shares in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
M&T Bank Corp Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Stifel Financial Corp Sells 24,859 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Brokerages Set DexCom, Inc. (NASDAQ:DXCM) Target Price at $98.00 - MarketBeat
DexCom (NASDAQ:DXCM) Price Target Raised to $94.00 - Defense World
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom - The Eastern Progress Online
DexCom Stock Price | DXCM Stock Quote, News, and History - Markets Insider
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Geode Capital Management LLC - MarketBeat
DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit - The Eastern Progress Online
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc.DXCM - The Eastern Progress Online
Continuous Glucose Monitoring Devices Market Set to Witness Significant Growth by 2024-2031: Dexcom, Inc., - EIN News
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - The Eastern Progress Online
DexCom Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The Gross Law Firm Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineDXCM - Kilgore News Herald
European court rules in favor of Abbott in Dexcom CGM patent spat - Mass Device
Public Employees Retirement System of Ohio Has $9.78 Million Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Quantinno Capital Management LP Decreases Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Faruqi & Faruqi Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024DXCM - The Eastern Progress Online
Abbott Gets Another Dexcom Patent Revoked At UPC - Law360
Dexcom, Orthofix, Spire Global, and Target Investigation - GlobeNewswire
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):